Co-financed Projects

For Certest Biotec R&D is part of its essence. In addition to carrying out research with its own funds, the company Certest Biotec has been the beneficiary of various competitive grants and has been awarded innovative public procurement tenders such as those detailed below.

Co-financed projects list

Cutting-edge therapies based on encapsulated nucleic acids
Execution period
06/2023 - 09/2025

Inhaled RNA vaccines against tuberculosis (VIRTB)
Execution period
01/2023 - 12/2024

Design and development of a medicine platform with a 5P (predictive, preventive, personalised, participatory, and population-based) approach using massive sequencing (NGS)
Execution period
09/2022 - 09/2024

Development of thermostable mRNA-based vaccines against the Delta variant of SARS-CoV-2
Execution period
09/2021 - 12/2023

Cutting-edge RNA Vaccine Design and Production Technologies in Aragon
Execution period
09/2021 - 09/2023

Industrial R&D projects within the Torres Quevedo and Industrial Doctorates programmes

CPI SALUD. Diagnosis and precision treatment in infectious diseases and cancer. ASURANT Challenge
Execution period
12/2020 – 06/2022

Newsletter

Receive all the news of Certest Biotec in your email